Background and Objectives

Last modified by Doug Maynard on 2016/04/04 15:21

Disclaimer:
This guideline represents the views of the CAPHC Inhaled Nitric Oxide Collaborative and was arrived at after careful consideration of the available evidence as well as a consensus building process.  The guideline does not override the responsibility of individual clinicians and organizations to make decisions and provide the most appropriate care to infants, children and youth in consultation with the patient and family/guardian.
 
The Canadian Association of Paediatric Health Centres and contributing hospitals are not responsible , nor liable for the use of the information provided

Any questions regarding this project should be directed toward Lisa Stromquist, National Coordinator Quality and Patient Safety, Canadian Association of Paediatric Health Centres (CAPHC) lstromquist@caphc.org

613-738-4164 ext 204.

Background and Introduction:

The Canadian Association of Paediatric Health Centres (CAPHC), in partnership with Medbuy Corporation established a National Collaborative to develop guidelines for the use of inhaled nitric oxide (iNO) in neonatal and paediatric patients.  This Collaborative includes content experts: physicians, respiratory therapists, nurses and quality improvement leaders from across the country.  It is Co-chaired by Zelia Da Silva, Clinical Director, Respiratory Services, SickKids, and Past Chair, Courtney Maguire, Director of Respiratory Therapy, Mount Sinai Hospital, and is facilitated by CAPHC.

For purposes of safety and operational optimization, paediatric centres have developed, independently, inhaled nitric oxide usage protocols/guidelines. Although these guidelines were developed via evidence based practice, there is a degree of diversity in practice in our children’s hospitals across the country.

We believe that the development and implementation of national standards will:

  1. Provide a focus for quality control and patient safety;  
  2. Reduce variations in practice;
  3. Promote evidence based use of inhaled nitric oxide;
  4. Result in cost savings
Vision Statement

“To establish a standardized approach for the delivery, utilization and weaning of inhaled Nitric Oxide for neonatal and paediatric patients across Canada. This project will have a strong emphasis on quality and safe care for this specialized patient population.”

Goals & Objectives of the Collaborative:

  1. Conduct an environmental scan of current practice in the delivery, utilization and weaning of inhaled nitric oxide for neonatal & paediatric patients within the Canadian context.
  2. Engage partners and stakeholders in the Collaborative 
  3. Reach national consensus on a set of guidelines for the use of inhaled nitric oxide for neonatal and paediatric patients

Process:

Audit Data And Tools:

Hospital for Sick Children inhaled Nitric Oxide Stewardship Program

CAPHC iNO Collaborative Guidelines:

  1. CAPHC Guidelines for Inhaled Nitric Oxide in Paediatrics: Dosing, Administration and Weaning
  2. CAPHC Guidelines for Inhaled Nitric Oxide in Neonates:  Dosing, Administration and Weaning
Created by Lisa Stromquist on 2015/09/23 16:12
   

Latest Activity

Yesterday

25 Feb

24 Feb

21 Feb

20 Feb

14 Feb

11 Feb

10 Feb

07 Feb

06 Feb